Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| PharmaSphere: Emerging Biotechnologies - Gene Therapy Market Analysis | ||
| By: PR Newswire Association LLC. - 07 Jul 2015 | Back to overview list |
|
NEW YORK, July 7, 2015 /PRNewswire/ -- Summary GlobalData's "PharmaSphere: Emerging Biotechnologies - Gene Therapy Market Analysis" report is an essential source of information and analysis on the gene therapy field. Using detailed company data, deal analysis, corporate strategy, and market trends analysis, GlobalData provides an in-depth analysis of the current and future growth drivers of the gene therapy market. The report discusses the key factors shaping and driving the gene therapy business, and provides insights on the competitive landscape and emerging strategies expected to significantly influence the market positions of companies currently involved in the development and commercialization of gene therapies. Highlights Key Questions Answered - What are the drivers of the gene therapy field? - Who are the leading companies involved in the development of gene therapies? - What are the major trends in gene therapy clinical trials? - What specific therapeutic areas and indications are receiving the most clinical research? - What progress has been made in terms of viral vector technology and gene delivery? - What specific business development activities are taking place in terms of partnerships or mergers and acquisitions (M&As)? - Has investor confidence been restored in the gene therapy field? Scope - This report provides market developments across the gene therapy field, including clinical trials, deals, and pipeline investments - Investment examined on both the industry and financial communities - Broad discussion on the science behind gene therapies, viral vectors, and gene delivery - Clinical trials activity examined across phase of development, therapy area, and indication. - This report offers a deep dive into the synergies behind partnering and acquisition activity - Deals activity examined across geography, entity type, company, financial advisor, phase of development, therapy area, indication, and mechanism of action - Pipeline profiles of 20 leading biotech companies developing gene therapies Reasons to buy - Identify the key players in the gene therapy market - Analyze and track the strategies that companies are using to strengthen their position in the gene therapy field; independent source for due diligence - Organize your sales and marketing strategy to identify companies with proprietary technologies in order to maximize opportunities for licensing, partnership, investment, or takeover - Understand the flow of investment from capital markets into the gene therapy field Read the full report: http://www.reportlinker.com/p03085663-summary/view-report.html About Reportlinker ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ SOURCE Reportlinker 
|
||
|
|
||
 | Back to overview list | |